MORE►
Colossal Biosciences
Image: Colossal Foundation
Dallas’ Colossal Foundation Donates $1M to Help Save Amphibians from Mass Extinction
by Lance Murray | Dec 17, 2024
“Helping to stop the spread of chytrid is a necessity to ensure healthy ecosystems globally,” said Colossal Foundation Director Matt James. “This isn’t optional. We have to give frogs a fighting chance and ensure they remain a vital part of our planet’s biodiversity for generations to come."
by Dallas Innovates | Staff Report |
Oct 25, 2024
The Innovation Awards 2025 recognizes 76 companies and trailblazers paving the way for the future of innovation in North Texas. Here's who made the finalists list.
MORE►
by Lance Murray |
Apr 17, 2024
Breaking is developing X-32, a breakthrough microbial discovery that destroys multiple types of plastic by breaking down hydrocarbon chains across different chemical structures quickly. The startup's goal is for X-32 to help address the global plastics crisis.
MORE►
by David Seeley |
Mar 29, 2024
Long's Austin-based Re:wild and Dallas-based Colossal Biosciences have announced a new partnership to accelerate global efforts "to save species on the brink of extinction, search for lost species, and restore key habitats for species recovery and rewilding."
MORE►
Photo: Michael Samples
Meet the Winners:
D CEO, Dallas Innovates Honor Top Innovators at 2024 Awards
by Dallas Innovates | Staff Report | Jan 25, 2024
At the annual Innovation Awards event, Dallas Innovates and D CEO revealed the winners in 17 categories and recognized all 74 North Texas finalists.
MORE►
by Nicole Ward, DRC Data Journalist |
Jan 9, 2024
Nextdoor.com co-founder and recent Dallas-Fort Worth transplant Nirav Tolia puts it simply: “It’s a great place to live.” Here's why Tolia and other dynamic newcomers believe the fast-growing region is a land of opportunity and community for 21st-century pioneers.
MORE►
by David Seeley |
Dec 20, 2023
The committee will provide a "crucial public body" for the discussion, development, and dissemination of plans related to Colossal's planned "de-extinction" and rewilding of the Tasmanian tiger—a slim, striped keystone species that was native to Australia, Tasmania, and New Guinea before being hunted to extinction some 100 years ago.
MORE►
by David Seeley |
Nov 27, 2023
“The dodo is the symbol of man-caused extinction,” Dallas-based Colossal Co-Founder and CEO Ben Lamm said last January. “It’s only fitting that Colossal works to reverse that.” The newly announced partnership with the MWF could help advance Colossal's efforts by restoring the dodo's natural habitat.
MORE►
Fatu in front and Najin in back are the last two known northern white rhinos alive on the planet. They live at Ol Pejeta conservancy in Kenya. [Photo: Ami Vitale]
Edge of Extinction: Pioneering Texas Biotech Colossal and BioRescue Race to Save the Northern White Rhino Species
by Quincy Preston and Lance Murray | Sep 19, 2023
With only two known living female northern white rhinos left, Colossal Biosciences and BioRescue have joined forces to fend off a looming extinction of the species. At the cutting edge of science, they're harnessing genetic technologies to rewrite the rhino's fate.
MORE►
by David Seeley |
Jun 21, 2023
Featuring "a diverse group of businesses helping chart an essential path forward," the TIME100 Most Influential Companies list features five companies that are either headquartered in North Texas or have a strong presence here. See who they are—and what they're doing to disrupt the status quo and innovate for the future.
MORE►
by David Seeley |
May 19, 2023
Google Cloud has unveiled its AI-powered Multiomics Suite, which aims to accelerate the discovery and interpretation of genomic data, helping companies design precision treatments. As part of the rollout, Google Cloud noted that Dallas-based Colossal Biosciences has adopted the Multiomics Suite, and that Colossal spinout Form Bio has been selected to help other organizations adopt it. See what the new suite can do—and how it could help life get scienced.
MORE►
by David Seeley |
Jan 31, 2023
Colossal says its efforts could help boost "the U.S. high-tech advantage." Its gene editing technologies "will make waves across sectors—in agriculture with new biofuels and preserving biodiversity, as well as in human health through improved gene therapy and vaccine development," the company said.
MORE►
[Illustration: ImagePixel via iStock]
Follow the Money: Medical Device Firm Orthofix Merges to Form Nearly $700M Revenue Business, Stealthy Men’s Health Startup Looks to Raise $2M, Dallas SPAC Targets $200M IPO, and More
by Kevin Cummings | Oct 17, 2022
In this week’s North Texas deal flow, you’ll also find news about Mavenir’s $155M raise, Pinnacle Realty Advisors raising $5M for ‘brokerage-as-a-service’ platform, Exela Technologies taking its European business unit public, American Airlines’ hydrogen fuel distribution investment, and more.
MORE►
by David Seeley |
Oct 11, 2022
The Central Intelligence Agency has invested in Colossal through its nonprofit VC investment arm, In-Q-Tel, reports The Intercept. Named in honor of Q—the tech genius from the James Bond novels and movies—the VC firm was founded in 1999 to keep U.S. intelligence agencies on the cutting edge of "innovative and impactful technologies coming out of Silicon Valley and beyond."
So why Colossal? "Strategically, it’s less about the mammoths and more about the capability," In-Q-Tel says.
MORE►
by David Seeley |
Oct 3, 2022
In August, Colossal Biosciences announced it is working to "de-extinct" the Tasmanian tiger with the help of an Australian university and “marsupial biobanking.” It didn't take long for the TV show "Jeopardy" to notice—and work it into an answer.
MORE►
by David Seeley |
Aug 16, 2022
Colossal is already working to "de-extinct" the woolly mammoth via a mammoth-elephant hybrid project. Now the Tasmanian tiger—which went extinct nearly 100 years ago due to human hunting—is the second species Colossal is seeking to bring back.
"We’re thrilled to be collaborating with Andrew Pask and the University of Melbourne to restore this amazing animal to Earth," said Ben Lamm, Colossal's co-founder and CEO.
MORE►
